The full catalogue covers 128 reference materials across 8 research areas, grouped a second time by 11 application categories. Each entry documents sequence class, molecular weight, purity specification, form and the documentation package supplied with the batch.
Grouped by the research area in which the reference material is studied. Material is supplied for laboratory investigation only.
An alternative index for buyers whose requirement is defined by a workflow rather than a research area — including bulk input material, custom synthesis and laboratory consumables.
Catalog reference materials for laboratory investigation.
Multi-component formulations for combination research.
Incretin and energy-pathway research compounds.
Materials for cellular mechanism and signalling study.
Secretagogue and growth-axis research peptides.
Matrix-remodelling research compounds.
Peptides studied in neural tissue research models.
Cosmetic peptide ingredients for formulation work.
Bulk input materials and bespoke synthesis.
Reconstitution and handling consumables.
Protein and hormone reference materials, supplied as characterised research materials.
Full listing of every catalogue reference, with classification, specification and documentation availability.
| Catalogue reference | Product | Classification | Sequence class | MW | Purity | Form | Research area | |
|---|---|---|---|---|---|---|---|---|
| CP-HGH191-001 | ![]() |
Growth factor | Protein / recombinant fragment | Reported on COA | 99%+ | 9 presentations | Growth Axis | Dossier |
| CP-CJC129-002 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Growth Axis | Dossier |
| CP-CJC129-003 | ![]() |
Peptide | 29-residue peptide | 3.44 kDa | 99%+ | 3 presentations | Growth Axis | Dossier |
| CP-AOD960-004 | ![]() |
Modified peptide | 129-residue peptide | 14.6 kDa | 99%+ | 3 presentations | Growth Axis | Dossier |
| CP-IGF1LR-005 | ![]() |
Growth factor | Protein / recombinant fragment | Reported on COA | 99%+ | 2 presentations | Growth Axis | Dossier |
| CP-DESIGF-006 | ![]() |
Growth factor | Protein / recombinant fragment | Reported on COA | 99%+ | 2mg*10vials | Growth Axis | Dossier |
| CP-GHRP2A-007 | ![]() |
Peptide | 28-residue peptide | 3.42 kDa | 99%+ | 3 presentations | Growth Axis | Dossier |
| CP-GHRP6A-008 | ![]() |
Peptide | 28-residue peptide | 3.42 kDa | 99%+ | 2 presentations | Growth Axis | Dossier |
| CP-TESAMO-009 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 5 presentations | Growth Axis | Dossier |
| CP-SERMOR-010 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Growth Axis | Dossier |
| CP-IPAMOR-011 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 4 presentations | Growth Axis | Dossier |
| CP-HEXARE-012 | ![]() |
Peptide | 26-residue peptide | 2.96 kDa | 99%+ | 2 presentations | Growth Axis | Dossier |
| CP-MGF-013 | ![]() |
Growth factor | Protein / recombinant fragment | Reported on COA | 99%+ | 2mg*10vials | Growth Axis | Dossier |
| CP-PEGMGF-014 | ![]() |
Modified growth factor | Protein / recombinant fragment | Reported on COA | 99%+ | 2 presentations | Growth Axis | Dossier |
| CP-IPAMOR-015 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 4 presentations | Growth Axis | Dossier |
| CP-HGHFRA-016 | ![]() |
Growth factor | Protein / recombinant fragment | Reported on COA | 99%+ | 6 presentations | Growth Axis | Dossier |
| CP-BPC157-017 | ![]() |
Peptide | GEPPPGKPADDAGLV (15 residues) | 1419.54 Da (free base) | 99%+ | 5 presentations | Tissue Remodelling | Dossier |
| CP-TB500T-018 | ![]() |
Polypeptide | Peptide | Reported on COA | 99%+ | 4 presentations | Tissue Remodelling | Dossier |
| CP-CARTAL-019 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Tissue Remodelling | Dossier |
| CP-ARA290-020 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Tissue Remodelling | Dossier |
| CP-CRYSTA-021 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Tissue Remodelling | Dossier |
| CP-TBFING-022 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2mg*10vials | Tissue Remodelling | Dossier |
| CP-LL37-023 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Tissue Remodelling | Dossier |
| CP-MELANO-024 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 10mg*10vials | Endocrine & Reproductive | Dossier |
| CP-MELANO-025 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Endocrine & Reproductive | Dossier |
| CP-PT141-026 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 10mg*10vials | Endocrine & Reproductive | Dossier |
| CP-P21-027 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Endocrine & Reproductive | Dossier |
| CP-KISSPE-028 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Endocrine & Reproductive | Dossier |
| CP-OXYTOC-029 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Endocrine & Reproductive | Dossier |
| CP-HCG-030 | ![]() |
Recombinant protein | Protein / recombinant fragment | Reported on COA | 99%+ | 4 presentations | Endocrine & Reproductive | Dossier |
| CP-GONADO-031 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Endocrine & Reproductive | Dossier |
| CP-HMG-032 | ![]() |
Recombinant protein | Protein / recombinant fragment | Reported on COA | 99%+ | 75 IU *10 vials | Endocrine & Reproductive | Dossier |
| CP-TRIPTO-033 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2mg*10vials | Endocrine & Reproductive | Dossier |
| CP-GHRH-034 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 5 presentations | Peptide Blends | Dossier |
| CP-GLOW-035 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 70mg*10vials | Peptide Blends | Dossier |
| CP-KLOW-036 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 80mg*10vials | Peptide Blends | Dossier |
| CP-CAGRIL-037 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 2 presentations | Peptide Blends | Dossier |
| CP-CAGRIL-038 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 2 presentations | Peptide Blends | Dossier |
| CP-TESAMO-039 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 15mg*10vials | Peptide Blends | Dossier |
| CP-BPC5MG-040 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 10mg*10vials | Peptide Blends | Dossier |
| CP-BPC10M-041 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 20mg*10vials | Peptide Blends | Dossier |
| CP-BPC15M-042 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 30mg*10vials | Peptide Blends | Dossier |
| CP-RETATI-043 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 60mg*10vials | Peptide Blends | Dossier |
| CP-SUPERS-044 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 10mg*10vials | Peptide Blends | Dossier |
| CP-ALPROS-045 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-SLUPP3-046 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-HYALUR-047 | ![]() |
Reagent | Not applicable | — | 99%+ | 5mg*10vials | Other Peptides | Dossier |
| CP-PNC27-048 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 4 presentations | Other Peptides | Dossier |
| CP-INSULI-049 | ![]() |
Recombinant protein | Protein / recombinant fragment | Reported on COA | 99%+ | 3ml/10vial | Other Peptides | Dossier |
| CP-TERIPA-050 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 10mg/vial, 10vial/kit | Other Peptides | Dossier |
| CP-FOLLIS-051 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 1mg *10 vials | Other Peptides | Dossier |
| CP-ACE031-052 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 1mg*10vials | Other Peptides | Dossier |
| CP-B12-053 | ![]() |
Reagent | Not applicable | — | 99%+ | 1mg/ml*10ml/vials | Other Peptides | Dossier |
| CP-BACWAT-054 | ![]() |
Reagent | Not applicable | — | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-ACETIC-055 | ![]() |
Reagent | Not applicable | — | 99%+ | 3ml*10vials | Other Peptides | Dossier |
| CP-ACETIC-056 | ![]() |
Reagent | Not applicable | — | 99%+ | 10ml*10vials | Other Peptides | Dossier |
| CP-BENZYL-057 | ![]() |
Reagent | Not applicable | — | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-AICAR-058 | ![]() |
Reagent | Not applicable | — | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-MK677-059 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 5mg10vials | Other Peptides | Dossier |
| CP-ADAMAX-060 | ![]() |
Reagent | Not applicable | — | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-DEMORP-061 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Other Peptides | Dossier |
| CP-PTDDBM-062 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 1mg*10vials | Other Peptides | Dossier |
| CP-GDF8-063 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 1mg*10vials | Other Peptides | Dossier |
| CP-FTTPAD-064 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Other Peptides | Dossier |
| CP-DERMOR-065 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Other Peptides | Dossier |
| CP-SNAP8-066 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-AU20-067 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Other Peptides | Dossier |
| CP-MATRIX-068 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Other Peptides | Dossier |
| CP-SEMAGL-069 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 11 presentations | Metabolic | Dossier |
| CP-TIRZEP-070 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 12 presentations | Metabolic | Dossier |
| CP-RETATR-071 | ![]() |
Peptide | 39-residue acylated peptide | 4.73 kDa | 99%+ | 10 presentations | Metabolic | Dossier |
| CP-GLP1-072 | ![]() |
Polypeptide | Peptide | Reported on COA | 99%+ | 10mg/vial, 10vial/kit | Metabolic | Dossier |
| CP-MOTSCH-073 | ![]() |
Peptide | 14-residue peptide | 1.62 kDa | 99%+ | 5 presentations | Metabolic | Dossier |
| CP-ELORAL-074 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Metabolic | Dossier |
| CP-MAZDUT-075 | ![]() |
Peptide | 40-residue acylated peptide | 4.71 kDa | 99%+ | 4 presentations | Metabolic | Dossier |
| CP-SURVOD-076 | ![]() |
Peptide | 43-residue acylated peptide | 5.04 kDa | 99%+ | 3 presentations | Metabolic | Dossier |
| CP-ADIPOT-077 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Metabolic | Dossier |
| CP-LIPOC-078 | ![]() |
Supplement precursor | Non-peptide precursor | Reported on COA | 99%+ | 10ml*10vials | Metabolic | Dossier |
| CP-LIPOCB-079 | ![]() |
Supplement precursor | Non-peptide precursor | Reported on COA | 99%+ | 10mg*10vials | Metabolic | Dossier |
| CP-LCARNI-080 | ![]() |
Supplement precursor | Non-peptide precursor | Reported on COA | 99%+ | 4 presentations | Metabolic | Dossier |
| CP-LIRAGL-081 | ![]() |
Peptide | 31-residue peptide | 3.75 kDa | 99%+ | 3 presentations | Metabolic | Dossier |
| CP-5AMINO-082 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Metabolic | Dossier |
| CP-CAGRIL-083 | ![]() |
Peptide | 39-residue acylated peptide | 4.39 kDa | 99%+ | 3 presentations | Metabolic | Dossier |
| CP-LEMONB-084 | ![]() |
Supplement precursor | Non-peptide precursor | Reported on COA | 99%+ | 10 ml/vial, 10vial/kit | Metabolic | Dossier |
| CP-CBL514-085 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 5mg*10vials | Metabolic | Dossier |
| CP-BETATR-086 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Metabolic | Dossier |
| CP-DULAGL-087 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Metabolic | Dossier |
| CP-PANCRA-088 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Neural Signalling | Dossier |
| CP-SELANK-089 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Neural Signalling | Dossier |
| CP-SEMAX-090 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Neural Signalling | Dossier |
| CP-KPV-091 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Neural Signalling | Dossier |
| CP-VIP-092 | ![]() |
Peptide | 28-residue peptide | 3.32 kDa | 99%+ | 2 presentations | Neural Signalling | Dossier |
| CP-DSIP-093 | ![]() |
Peptide | 9-residue peptide | 1.05 kDa | 99%+ | 6 presentations | Neural Signalling | Dossier |
| CP-CEREBR-094 | ![]() |
Polypeptide | Polypeptide mixture | Reported on COA | 99%+ | 600 mg/vial, 10vial/kit | Neural Signalling | Dossier |
| CP-DIHEXA-095 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Neural Signalling | Dossier |
| CP-PE2228-096 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Neural Signalling | Dossier |
| CP-OREXIN-097 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Neural Signalling | Dossier |
| CP-OREXIN-098 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 10mg*10vials | Neural Signalling | Dossier |
| CP-ACTH13-099 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Neural Signalling | Dossier |
| CP-HUMANI-100 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Longevity & Immunology | Dossier |
| CP-SS31-101 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Longevity & Immunology | Dossier |
| CP-FOXO4D-102 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 10mg*10vials | Longevity & Immunology | Dossier |
| CP-EPITAL-103 | ![]() |
Peptide | 4-residue peptide | 0.48 kDa | 99%+ | 2 presentations | Longevity & Immunology | Dossier |
| CP-THYMOS-104 | ![]() |
Polypeptide | Peptide | Reported on COA | 99%+ | 4 presentations | Longevity & Immunology | Dossier |
| CP-TESTAG-105 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Longevity & Immunology | Dossier |
| CP-PROSTA-106 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Longevity & Immunology | Dossier |
| CP-NAD-107 | ![]() |
Peptide blend | Multi-component peptide | Blend-dependent | 99%+ | 3 presentations | Longevity & Immunology | Dossier |
| CP-GHKCU-108 | ![]() |
Peptide | 3-residue peptide | 0.34 kDa | 99%+ | 2 presentations | Longevity & Immunology | Dossier |
| CP-OVAGEN-109 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 2 presentations | Longevity & Immunology | Dossier |
| CP-PINEAL-110 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Longevity & Immunology | Dossier |
| CP-LIPOCF-111 | ![]() |
Supplement precursor | Non-peptide precursor | Reported on COA | 99%+ | 10ml*10vials | Longevity & Immunology | Dossier |
| CP-LIVAGE-112 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Longevity & Immunology | Dossier |
| CP-VILON-113 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Longevity & Immunology | Dossier |
| CP-THYMAL-114 | ![]() |
Polypeptide | Peptide | Reported on COA | 99%+ | 2 presentations | Longevity & Immunology | Dossier |
| CP-GLUTAT-115 | ![]() |
Peptide | Tripeptide, 3-residue | 0.31 kDa | 99%+ | 3 presentations | Longevity & Immunology | Dossier |
| CP-BRONCH-116 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Longevity & Immunology | Dossier |
| CP-CHONLU-117 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Longevity & Immunology | Dossier |
| CP-CARDIO-118 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Longevity & Immunology | Dossier |
| CP-CORTAG-119 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 20mg/vial, 10vial/kit | Longevity & Immunology | Dossier |
| CP-VESUGE-120 | ![]() |
Peptide | Peptide | Reported on COA | 99%+ | 3 presentations | Longevity & Immunology | Dossier |
| CP-RETA-121 | ![]() |
Modified peptide | 39-residue acylated peptide | 4.73 kDa | 99%+ | Lyophilized powder | Metabolic | Dossier |
| CP-TIRZ-122 | ![]() |
Modified peptide | 39-residue acylated peptide | 4.81 kDa | 99%+ | Lyophilized powder | Metabolic | Dossier |
| CP-LCARNI-123 | ![]() |
Supplement precursor | Non-peptide quaternary amine | 0.16 kDa | 99%+ | Lyophilized powder | Metabolic | Dossier |
| CP-LCARNI-124 | ![]() |
Supplement precursor | Non-peptide quaternary amine | 0.16 kDa | 99%+ | Lyophilized powder | Metabolic | Dossier |
| CP-GLUTAT-125 | ![]() |
Peptide | Tripeptide, 3-residue | 0.31 kDa | 99%+ | Lyophilized powder | Longevity & Immunology | Dossier |
| CP-KAMI1-126 | ![]() |
Culture reagent | Non-peptide additive | — | 99%+ | Sterile solution | Other Peptides | Dossier |
| CP-CUSTOM-127 | ![]() |
Custom synthesis | Per specification | — | Negotiable, stated on the quotation | Lyophilized powder | Other Peptides | Dossier |
| CP-PEPTID-128 | ![]() |
Bulk material | Per specification | — | 99%+ | Lyophilized powder | Other Peptides | Dossier |
Send the catalogue reference or target sequence, required purity, quantity and destination on WhatsApp. The procurement desk returns a formal quotation with the documentation package and lead time.